High Dose PPI denied as not FDA-approved for this use by Cigna?

Cigna's specific coverage criteria for high dose ppi are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Cigna May Deny High-Dose PPI as "Not FDA-Approved"

High-dose proton pump inhibitor (PPI) therapy typically involves prescribing at a dose or frequency beyond the specific indication listed in the FDA-approved prescribing label for that particular PPI product. Cigna may issue a "not FDA-approved" denial when the prescribed regimen does not map exactly to a labeled indication — even if the prescribing physician has strong clinical justification for the approach.

This type of denial is almost always appealable. The FDA-approved label contains the approved indications and dosing ranges; your prescriber's recommended regimen may fall within label parameters for a different labeled indication, or the prescriber may be able to demonstrate that the regimen is consistent with accepted medical practice under a recognized clinical framework. The distinction matters for your appeal.

## Federal Appeal Rights

You have layered federal protections:

• ACA §2719 / external review: If your plan is subject to the ACA (most commercial, non-grandfathered plans), you may request an Independent Review Organization (IRO) external review after exhausting internal appeals. The standard window is approximately four months from the date of denial, though your Summary Plan Description will state the exact deadline. An expedited external review (often resolved within 72 hours) is available when your health is at serious risk.
• ERISA §503 (self-funded plans): Requires a full-and-fair review of every claim denial, with a written explanation of the specific reason and the plan criteria applied.

## What to Gather

1. Diagnosis confirmation — chart notes and any applicable test results establishing the condition being treated. 2. Prior treatment history — a dated list of other acid-suppression or related therapies tried, with outcomes and reasons for discontinuation or inadequacy. 3. Clinical severity documentation — endoscopy, pH monitoring, or specialist notes quantifying disease burden in the chart. 4. Prescriber medical-necessity letter — a signed letter explaining why this specific regimen is medically necessary for this patient, referencing the applicable professional society guideline organization (e.g., the American College of Gastroenterology) without relying on numbers that could be disputed. 5. FDA label excerpt — highlight the indication and dosing range your prescriber is relying upon.

## Criteria-Mapping Structure

Pull Cigna's published medical/coverage policy for PPI therapy and the FDA prescribing label. Create a two-column table:

| Cigna/FDA Requirement | Chart Evidence Satisfying It | |---|---| | Each criterion from the policy | Exact date, note, or result from the medical record |

Present this table in your appeal letter so the reviewer cannot overlook any element. If Cigna's denial letter cites a specific policy criterion, address it line by line. Request the complete clinical criteria Cigna applied if they were not provided with the denial.